Soluble HLA-G expression and renal graft acceptance

Area of Science:

• Immunology
• Transplantation Science
• Clinical Chemistry

Background:

• Soluble human leukocyte antigen-G (sHLA-G) is an immunosuppressive molecule.
• Understanding sHLA-G's role in renal transplantation is crucial for improving patient outcomes.
• Previous studies suggest HLA antibodies are linked to transplant failure.

Purpose of the Study:

• To investigate the presence and significance of soluble HLA-G (sHLA-G) in serial serum samples from renal transplant recipients.
• To determine the association between sHLA-G levels and renal transplant function or rejection.
• To explore the relationship between sHLA-G and the presence of HLA IgG antibodies.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to measure sHLA-G levels in 330 serial serum samples from 65 renal transplant patients.
• Patient samples were categorized into functioning transplant and transplant rejection groups.
• Previously tested data on IgG/IgM antibodies to HLA and MICA antibodies were utilized.

Main Results:

• Consistent sHLA-G expression or positivity was observed in 50% of patients with functioning transplants versus 20.5% of patients who rejected their transplants (p=0.013).
• sHLA-G was negatively associated with HLA IgG antibodies (p=0.005), which are known to be linked to transplant failure.
• Approximately 30% of renal transplant patients in this preliminary survey had detectable sHLA-G in their serum.

Conclusions:

• sHLA-G is associated with functioning renal transplants.
• sHLA-G shows a negative association with allograft failure, particularly chronic rejection.
• The findings suggest sHLA-G may play a protective role in renal transplantation, warranting further investigation.